Christen Lynn Schmidt, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 193461 E County Road 304, Ft Supply, OK 73841 Phone: 580-733-2311 Fax: 580-766-2316 |
News Archive
Axolotl Corp., the nationwide leader in health information exchange (HIE) services and solutions, celebrates fifteen successful years of software development and HIE implementation. Since its founding in 1995, Axolotl has been providing advanced Clinical Networking™ solutions to meet the diverse and changing needs of physicians, hospitals, regional health information organizations (RHIOs) and statewide HIEs to achieve interoperability across entire medical trading areas.
Sunesis Pharmaceuticals, Inc. today reported that it has completed enrollment in the REVEAL-1 (Response Evaluation of VorEloxin in AmL) trial, a Phase 2 dose regimen optimization trial of single agent voreloxin in newly diagnosed elderly acute myeloid leukemia (AML) patients who are unlikely to benefit from standard induction chemotherapy. A total of 113 patients were enrolled and dosed according to one of three dosing schedules.
Using an experimental model to simulate the blood-brain barrier, scientists in Sweden reported in unprecedented detail how antioxidants protect the brain from inflammation caused by neurodegenerative diseases such as Alzheimer's and Parkinson's.
Results from a new study identify a biomarker that may be useful for predicting the outcome of treatment for neuroblastoma, the most common cancer in young children.
The Alzheimer's Society has expressed serious concern at the interpretation of a new study into the effectiveness of drugs for dementia, published in The Lancet.
› Verified 4 days ago